Literature DB >> 27566548

Allosteric Activation of SAMHD1 Protein by Deoxynucleotide Triphosphate (dNTP)-dependent Tetramerization Requires dNTP Concentrations That Are Similar to dNTP Concentrations Observed in Cycling T Cells.

Zhonghua Wang1, Akash Bhattacharya1, Jessica Villacorta1, Felipe Diaz-Griffero2, Dmitri N Ivanov3.   

Abstract

SAMHD1 is a dNTP hydrolase, whose activity is required for maintaining low dNTP concentrations in non-cycling T cells, dendritic cells, and macrophages. SAMHD1-dependent dNTP depletion is thought to impair retroviral replication in these cells, but the relationship between the dNTPase activity and retroviral restriction is not fully understood. In this study, we investigate allosteric activation of SAMHD1 by deoxynucleotide-dependent tetramerization and measure how the lifetime of the enzymatically active tetramer is affected by different dNTP ligands bound in the allosteric site. The EC50dNTP values for SAMHD1 activation by dNTPs are in the 2-20 μm range, and the half-life of the assembled tetramer after deoxynucleotide depletion varies from minutes to hours depending on what dNTP is bound in the A2 allosteric site. Comparison of the wild-type SAMHD1 and the T592D mutant reveals that the phosphomimetic mutation affects the rates of tetramer dissociation, but has no effect on the equilibrium of allosteric activation by deoxynucleotides. Collectively, our data suggest that deoxynucleotide-dependent tetramerization contributes to regulation of deoxynucleotide levels in cycling cells, whereas in non-cycling cells restrictive to retroviral replication, SAMHD1 activation is likely to be achieved through a distinct mechanism.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  autoimmune disease; human immunodeficiency virus (HIV); innate immunity; nucleoside/nucleotide metabolism; retrovirus

Mesh:

Substances:

Year:  2016        PMID: 27566548      PMCID: PMC5076810          DOI: 10.1074/jbc.C116.751446

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  The purification and properties of deoxyguanosine triphosphate triphosphohydrolase from Escherichia coli.

Authors:  D Seto; S K Bhatnagar; M J Bessman
Journal:  J Biol Chem       Date:  1988-01-25       Impact factor: 5.157

2.  SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

Authors:  Hanna-Mari Baldauf; Xiaoyu Pan; Elina Erikson; Sarah Schmidt; Waaqo Daddacha; Manja Burggraf; Kristina Schenkova; Ina Ambiel; Guido Wabnitz; Thomas Gramberg; Sylvia Panitz; Egbert Flory; Nathaniel R Landau; Serkan Sertel; Frank Rutsch; Felix Lasitschka; Baek Kim; Renate König; Oliver T Fackler; Oliver T Keppler
Journal:  Nat Med       Date:  2012-11       Impact factor: 53.440

3.  SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates.

Authors:  Hichem Lahouassa; Waaqo Daddacha; Henning Hofmann; Diana Ayinde; Eric C Logue; Loïc Dragin; Nicolin Bloch; Claire Maudet; Matthieu Bertrand; Thomas Gramberg; Gianfranco Pancino; Stéphane Priet; Bruno Canard; Nadine Laguette; Monsef Benkirane; Catherine Transy; Nathaniel R Landau; Baek Kim; Florence Margottin-Goguet
Journal:  Nat Immunol       Date:  2012-02-12       Impact factor: 25.606

4.  The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Sarah Amie; Laura Anh Nguyen; Baek Kim; Marina Tuzova; Felipe Diaz-Griffero
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

5.  A unique deoxyguanosine triphosphatase is responsible for the optA1 phenotype of Escherichia coli.

Authors:  B B Beauchamp; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

6.  HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.

Authors:  David C Goldstone; Valerie Ennis-Adeniran; Joseph J Hedden; Harriet C T Groom; Gillian I Rice; Evangelos Christodoulou; Philip A Walker; Geoff Kelly; Lesley F Haire; Melvyn W Yap; Luiz Pedro S de Carvalho; Jonathan P Stoye; Yanick J Crow; Ian A Taylor; Michelle Webb
Journal:  Nature       Date:  2011-11-06       Impact factor: 49.962

7.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.

Authors:  Kasia Hrecka; Caili Hao; Magda Gierszewska; Selene K Swanson; Malgorzata Kesik-Brodacka; Smita Srivastava; Laurence Florens; Michael P Washburn; Jacek Skowronski
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

8.  dNTP pool modulation dynamics by SAMHD1 protein in monocyte-derived macrophages.

Authors:  Joseph A Hollenbaugh; Sijia Tao; Gina M Lenzi; Sulryung Ryu; Dong-Hyun Kim; Felipe Diaz-Griffero; Raymond F Schinazi; Baek Kim
Journal:  Retrovirology       Date:  2014-08-27       Impact factor: 4.602

9.  Tetramerization of SAMHD1 is required for biological activity and inhibition of HIV infection.

Authors:  Junpeng Yan; Sarabpreet Kaur; Maria DeLucia; Caili Hao; Jennifer Mehrens; Chuanping Wang; Marcin Golczak; Krzysztof Palczewski; Angela M Gronenborn; Jinwoo Ahn; Jacek Skowronski
Journal:  J Biol Chem       Date:  2013-02-20       Impact factor: 5.157

10.  Contribution of oligomerization to the anti-HIV-1 properties of SAMHD1.

Authors:  Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Tommy E White; Laura Nguyen; Akash Bhattacharya; Zhonghua Wang; Borries Demeler; Sarah Amie; Caitlin Knowlton; Baek Kim; Dmitri N Ivanov; Felipe Diaz-Griffero
Journal:  Retrovirology       Date:  2013-11-12       Impact factor: 4.602

View more
  11 in total

1.  p21 Restricts HIV-1 in Monocyte-Derived Dendritic Cells through the Reduction of Deoxynucleoside Triphosphate Biosynthesis and Regulation of SAMHD1 Antiviral Activity.

Authors:  Jose Carlos Valle-Casuso; Awatef Allouch; Annie David; Gina M Lenzi; Lydia Studdard; Françoise Barré-Sinoussi; Michaela Müller-Trutwin; Baek Kim; Gianfranco Pancino; Asier Sáez-Cirión
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

2.  The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB.

Authors:  Cindy Buffone; Juliane Kutzner; Silvana Opp; Alicia Martinez-Lopez; Anastasia Selyutina; Si Ana Coggings; Lydia R Studdard; Lingmei Ding; Baek Kim; Paul Spearman; Torsten Schaller; Felipe Diaz-Griffero
Journal:  Virology       Date:  2019-03-30       Impact factor: 3.616

3.  Phosphorylation of SAMHD1 Thr592 increases C-terminal domain dynamics, tetramer dissociation and ssDNA binding kinetics.

Authors:  Benjamin Orris; Kevin W Huynh; Mark Ammirati; Seungil Han; Ben Bolaños; Jason Carmody; Matthew D Petroski; Benedikt Bosbach; David J Shields; James T Stivers
Journal:  Nucleic Acids Res       Date:  2022-07-22       Impact factor: 19.160

Review 4.  SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity.

Authors:  Christopher H Mauney; Thomas Hollis
Journal:  Autoimmunity       Date:  2018-03-27       Impact factor: 2.815

5.  The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1.

Authors:  Kirsten M Knecht; Olga Buzovetsky; Constanze Schneider; Dominique Thomas; Vishok Srikanth; Lars Kaderali; Florentina Tofoleanu; Krystle Reiss; Nerea Ferreirós; Gerd Geisslinger; Victor S Batista; Xiaoyun Ji; Jindrich Cinatl; Oliver T Keppler; Yong Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-10       Impact factor: 11.205

6.  Nucleic acid binding by SAMHD1 contributes to the antiretroviral activity and is enhanced by the GpsN modification.

Authors:  Akash Bhattacharya; Mirjana Persaud; Corey H Yu; Alexander B Taylor; Zhonghua Wang; Angel Bulnes-Ramos; Joella Xu; Anastasia Selyutina; Alicia Martinez-Lopez; Kristin Cano; Borries Demeler; Baek Kim; Stephen C Hardies; Felipe Diaz-Griffero; Dmitri N Ivanov
Journal:  Nat Commun       Date:  2021-02-02       Impact factor: 17.694

Review 7.  Mechanistic Interplay between HIV-1 Reverse Transcriptase Enzyme Kinetics and Host SAMHD1 Protein: Viral Myeloid-Cell Tropism and Genomic Mutagenesis.

Authors:  Nicole E Bowen; Adrian Oo; Baek Kim
Journal:  Viruses       Date:  2022-07-26       Impact factor: 5.818

8.  Functionality of Redox-Active Cysteines Is Required for Restriction of Retroviral Replication by SAMHD1.

Authors:  Zhonghua Wang; Akash Bhattacharya; Tommy White; Cindy Buffone; Aine McCabe; Laura A Nguyen; Caitlin N Shepard; Sammy Pardo; Baek Kim; Susan T Weintraub; Borries Demeler; Felipe Diaz-Griffero; Dmitri N Ivanov
Journal:  Cell Rep       Date:  2018-07-24       Impact factor: 9.423

Review 9.  SAMHD1 Functions and Human Diseases.

Authors:  Si'Ana A Coggins; Bijan Mahboubi; Raymond F Schinazi; Baek Kim
Journal:  Viruses       Date:  2020-03-31       Impact factor: 5.048

10.  Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.

Authors:  Sean G Rudd; Nikolaos Tsesmetzis; Kumar Sanjiv; Cynthia Bj Paulin; Lakshmi Sandhow; Juliane Kutzner; Ida Hed Myrberg; Sarah S Bunten; Hanna Axelsson; Si Min Zhang; Azita Rasti; Petri Mäkelä; Si'Ana A Coggins; Sijia Tao; Sharda Suman; Rui M Branca; Georgios Mermelekas; Elisée Wiita; Sun Lee; Julian Walfridsson; Raymond F Schinazi; Baek Kim; Janne Lehtiö; Georgios Z Rassidakis; Katja Pokrovskaja Tamm; Ulrika Warpman-Berglund; Mats Heyman; Dan Grandér; Sören Lehmann; Thomas Lundbäck; Hong Qian; Jan-Inge Henter; Torsten Schaller; Thomas Helleday; Nikolas Herold
Journal:  EMBO Mol Med       Date:  2020-01-17       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.